Inhibrx
INBX
96 hedge funds and large institutions have $139M invested in Inhibrx in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 11 closing their positions.
134% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $1.7M
100% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 18
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
12% more funds holding
Funds holding: 86 → 96 (+10)
2% more capital invested
Capital invested by funds: $137M → $139M (+$2.58M)
5.2% less ownership
Funds ownership: 66.65% → 61.45% (-5.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$1.05M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$1.02M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$958K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$760K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$731K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$4.34M |
| 2 |
TAL
TIG Advisors LLC
New York
|
-$3.45M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.64M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$2.37M |
| 5 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$1.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WCMNY
101
Westchester Capital Management (New York)
Valhalla,
New York
| – | -$912K | -64,339 | Closed |
|
102
Wellington Management Group
Boston,
Massachusetts
| – | -$449K | -31,678 | Closed |
|
103
Franklin Resources
San Mateo,
California
| – | -$320K | -22,577 | Closed |
|
104
Invesco
Atlanta,
Georgia
| – | -$303K | -21,386 | Closed |
|
|
CF
105
Cantor Fitzgerald
New York
| – | -$259K | -18,263 | Closed |
|
|
AGM
106
Alpine Global Management
New York
| – | -$176K | -12,445 | Closed |
|
107
Bessemer Group
Woodbridge,
New Jersey
| – | +$169 | +12 | New |
|
INBX Hedge Fund Activity: Q3 2024 in Review
96 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Inhibrx (INBX) for Q3 2024, worth a combined $139M — up 1.9% from $137M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new INBX positions and 11 closed out — a net gain of 10 holders — while 36 added to existing stakes and 18 trimmed.
The largest buyer was Walleye Capital, adding an estimated $1.05M. The largest seller was Alpine Associates Management, exiting entirely with an estimated $4.34M sold.
- 96 institutional investors held Inhibrx (INBX) as of Q3 2024, up from 86 in Q2 2024.
- Funds reported $139M of Inhibrx stock for Q3 2024, up 1.9% quarter-over-quarter.
- 21 funds opened new Inhibrx positions in Q3 2024 and 11 closed out, a net change of +10 holders.
- The largest Inhibrx buyer in Q3 2024 was Walleye Capital, an estimated $1.05M added.
- The largest Inhibrx seller in Q3 2024 was Alpine Associates Management, an estimated $4.34M sold.
Based on aggregated 13F filings for Q3 2024.